Alnylam Pharmaceuticals
ALNY
#698
Rank
$35.71 B
Marketcap
$267.47
Share price
-5.54%
Change (1 day)
-16.55%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company